HomeACTU • NASDAQ
add
Actuate Therapeutics Inc
Previous close
$8.75
Day range
$8.14 - $9.14
Year range
$5.52 - $10.16
Market cap
171.10M USD
Avg Volume
46.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.44M | -2.67% |
Net income | -6.57M | -18.97% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 351.71K | — |
Total assets | 1.73M | — |
Total liabilities | 20.55M | — |
Total equity | -18.82M | — |
Shares outstanding | 19.53M | — |
Price to book | -0.13 | — |
Return on assets | -613.56% | — |
Return on capital | 139.42% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -6.57M | -18.97% |
Cash from operations | -2.67M | 47.74% |
Cash from investing | — | — |
Cash from financing | 957.04K | -42.73% |
Net change in cash | -1.72M | 50.17% |
Free cash flow | 50.61K | — |
About
Founded
2015
Headquarters
Website
Employees
11
